Pfizer tests heart drug safety in healthy volunteers
NCT ID NCT07455240
First seen Mar 07, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study looked at how a new medicine called PF-07328948 is handled by the body and whether it is safe in healthy Chinese adults. Ten participants took the drug daily for 7 days. The goal was to gather early safety information for a possible future heart failure treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 101100, China
Conditions
Explore the condition pages connected to this study.